Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats

被引:20
|
作者
Jin Ming [1 ]
Wang Lin [1 ]
Wu Yan [1 ]
Zang Bao-xia [1 ]
Tan Li [1 ]
机构
[1] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Pharmacol, Beijing 100029, Peoples R China
关键词
hydroxysafflor yellow A; pulmonary fibrosis; pulmonary inflammation; nuclear factor-kappa B p65; alpha-smooth muscle actin; Chinese medicine; NECROSIS-FACTOR-ALPHA; ACUTE LUNG INJURY; IL-1-BETA; FIBROGENESIS; EXPRESSION; DISEASES; MODEL; MICE;
D O I
10.1007/s11655-017-2094-z
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
To observe the effect of hydroxysafflor yellow A (HSYA), an active ingredient of a traditional Chinese herbal medicine Carthamus tinctorius L., on lung inflflammation and pulmonary fibrosis induced by bleomycin (BLM) in rats. Animals were divided into 6 groups including normal group, model group, three HSYA groups and dexamethasone (DXM) group. Three doses of HSYA (35.6, 53.3, and 80.0 mgaEuro cent kg(-1)aEuro cent day(-1)) were intraperitoneally (i.p.) injected in rats for 3 weeks after BLM administration and DXM was used as the positive control (n=8 or 12). Arterial blood gas was assayed and morphological changes were observed. Lung mRNA expressions of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6 and some cytokines in lung tissue were detected by real-time polymerase chain reaction. Nuclear factor-kappa B p65 or alpha-smooth muscle actin (alpha-SMA) protein distribution in rat lung tissue was observed by immunohistochemistry. On the 7th day after BLM administration, lung tissue showed serious inflammation. Treatment with HSYA or DXM ameliorated lung inflammation. After treatment with HSYA or DXM, oxygen partial pressure (PaO2) increased (HSYA 80.0 mgaEuro cent kg(-1), P < 0.01) and CO2 partial pressure (PaCO2) decreased (HSYA 53.3, 80.0 mgaEuro cent kg(-1), P < 0.05). Moreover, the mRNA expression of TNF-alpha, IL-1 beta, and IL-6; and the number of NF-kappa B p65 positive cells was lower in HSYA 53.3 and 80.0 mgaEuro cent kg(-1) groups than those in the model group (all P < 0.05). Twenty-one days after BLM administration, HSYA or DXM treatment ameliorated fibrosis, increased PaO2 (HSYA 53.3, 80.0 mgaEuro cent kg-1, P < 0.01), and decreased PaCO2 (53.3 and 80.0 mgaEuro cent kg-1, P < 0.05). Further, the mRNA expression of TGF-beta 1, alpha-SMA, and collagen I as well as the number of alpha-SMA positive cells increased in the model group and HSYA can attenuate these changes (53.3, 80.0 mgaEuro cent kg(-1), P < 0.05). Hematoxylin and eosin and Masson's trichrome staining indicated that the fibrosis and collagen deposition were ameliorated in HSYA groups (53.3, 80.0 mgaEuro cent kg(-1), P < 0.05). HSYA could alleviate acute lung inflflammation and chronic pulmonary fibrosis induced by BLM in rats.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [1] Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats
    Ming Jin
    Lin Wang
    Yan Wu
    Bao-xia Zang
    Li Tan
    Chinese Journal of Integrative Medicine, 2018, 24 : 32 - 39
  • [2] Protective Effect of Hydroxysafflor Yellow A on Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Rats
    JIN Ming
    WANG Lin
    WU Yan
    ZANG Bao-xia
    TAN Li
    Chinese Journal of Integrative Medicine, 2018, 24 (01) : 32 - 39
  • [3] Protective Effect of Hydroxysafflor Yellow A on Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Rats
    JIN Ming
    WANG Lin
    WU Yan
    ZANG Bao-xia
    TAN Li
    Chinese Journal of Integrative Medicine, 2018, (01) : 32 - 39
  • [4] Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice
    Jin, Ming
    Wu, Yan
    Wang, Lin
    Zang, Baoxia
    Tan, Li
    PHYTOTHERAPY RESEARCH, 2016, 30 (04) : 577 - 587
  • [5] Protective Effect of Hydroxysafflor Yellow A on Isoproterenol-Induced Myocardial Fibrosis in Rats
    Li, Yuan
    Wu, Xiangnian
    Mao, Yifan
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2019, 9 (11) : 1563 - 1570
  • [6] Protective effect of dexpanthenol on bleomycin-induced pulmonary fibrosis in rats
    Hilal Ermis
    Hakan Parlakpinar
    Gazi Gulbas
    Nigar Vardi
    Alaadin Polat
    Asli Cetin
    Talat Kilic
    Zeynep Ayfer Aytemur
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, 386 : 1103 - 1110
  • [7] Protective effect of dexpanthenol on bleomycin-induced pulmonary fibrosis in rats
    Ermis, Hilal
    Parlakpinar, Hakan
    Gulbas, Gazi
    Vardi, Nigar
    Polat, Alaadin
    Cetin, Asli
    Kilic, Talat
    Aytemur, Zeynep Ayfer
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 (12) : 1103 - 1110
  • [8] in pulmonary fibrosis induced by bleomycin in rats on the effects of inflammation and fibrosis of erdosteine
    Karapolat, Sami
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2009, 57 (02): : 244 - 245
  • [9] Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin
    Erden, Ersin Sukru
    Kirkil, Gamze
    Deveci, Figen
    Ilhan, Nevin
    Cobanoglu, Bengu
    Turgut, Teyfik
    Muz, Mehmet Hamdi
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2008, 56 (02): : 127 - 138
  • [10] PROTECTIVE EFFICACY OF PIRFENIDONE IN RATS WITH PULMONARY FIBROSIS INDUCED BY BLEOMYCIN
    Demirkol, Baris
    Gul, Sule
    Cortuk, Mustafa
    Fener, Neslihan Akanil
    Yavuzsan, Eminegul
    Eren, Ramazan
    Baydili, Kursad Nuri
    Cekmen, Mustafa Baki
    Cetinkaya, Erdogan
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2023, 40 (03)